Clinical effectiveness of additional primary SARS-CoV-2 vaccine doses for solid organ transplant recipients.

Radcliffe, Christopher; Azar, Marwan M; Cohen, Elizabeth; Tucker, Mollie; Grubaugh, Nathan D; Malinis, Maricar

Radcliffe, Christopher; Azar, Marwan M; Cohen, Elizabeth; Tucker, Mollie; Grubaugh, Nathan D; Malinis, Maricar.

Afiliação

Radcliffe C; Yale University School of Medicine, New Haven, Connecticut, USA.
Azar MM; Section of Infectious Diseases, Yale University School of Medicine, New Haven, Connecticut, USA.
Cohen E; Yale New Haven Transplant Center, New Haven, Connecticut, USA.
Tucker M; Section of Infectious Diseases, Yale University School of Medicine, New Haven, Connecticut, USA.
Grubaugh ND; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, USA.
Malinis M; Section of Infectious Diseases, Yale University School of Medicine, New Haven, Connecticut, USA.

Clin Transplant ; 36(3): e14601, 2022 03.

Article em En | MEDLINE | ID: mdl-35064939

Assuntos

COVID-19; Transplante de Órgãos; COVID-19/epidemiologia; COVID-19/prevenção & controle; Vacinas contra COVID-19; Humanos; SARS-CoV-2; Transplantados; Resultado do Tratamento

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Órgãos / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google